SR One Investor
SR One is the corporate venture capital arm of GlaxoSmithKline.
Invests into
.jpg)
Technology:
Cell_Therapies
Industry:
Investor
Headquarters:
Cambridge, Massachusetts, United States
Zip:
NA
Founded Date:
1985-01-01
Employees Number:
1-10
Funding Status:
N/A
Investor Type:
Corporate Venture Capital
Investment Stage:
Series A, Series C
Number Of Exits:
56
Acquisitions Number:
NA
Investors Number:
NA
Estimated Revenue:
$1M to $10M
Register and Claim Ownership